Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 55, Number 2, July 25, 2000
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hy, L. X.
Right arrow Articles by Keller, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hy, L. X.
Right arrow Articles by Keller, D. M.
Neurology 2000;55:198-204
© 2000 American Academy of Neurology


Articles

Prevalence of AD among whites

A summary by levels of severity

Lê X. Hy, PhD and Donald M. Keller, PhD, MPH

From the Department of Psychology (Dr. Hy), Seattle University, WA; and the Health, Education, and Human Services Division (Dr. Keller), US General Accounting Office, Washington, DC.

Address correspondence to Dr. Keller, US General Accounting Office, 441 G Street, NW, Room 5A14, Washington, DC 20548.

OBJECTIVE: To determine age- and sex-specific AD prevalence rates for whites using each of four severity-based definitions of a case: a person diagnosed as having at least questionable AD, one diagnosed as having at least mild AD, one diagnosed as having moderate or severe AD, and one diagnosed as having severe AD.

METHODS: Data from 21 studies of Europeans and North Americans were pooled.

RESULTS: Empirically, one study, from East Boston, is an outlier. Applied to the US population of 1996, the obtained estimates yield a prevalence of 1.7 to 1.9 million cases, depending on whether the outlier study is excluded or included.

CONCLUSIONS: With disease severity taken into account, estimates of AD prevalence from white populations are more consistent than is usually acknowledged. By including disease severity in the case definition, variations in reported rates are much reduced. The outlier status of the East Boston study appears to result from the use of a definition of AD that differs from that used in the other 20 studies. Alternative explanations of the discrepancy between these estimates and the common estimate of 4 million cases are discussed.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. Miyashita, H. Arai, T. Asada, M. Imagawa, E. Matsubara, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al.
Genetic association of CTNNA3 with late-onset Alzheimer's disease in females
Hum. Mol. Genet., December 1, 2007; 16(23): 2854 - 2869.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. Holsinger, J. Deveau, M. Boustani, and J. W. Williams Jr
Does This Patient Have Dementia?
JAMA, June 6, 2007; 297(21): 2391 - 2404.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. Stenset, L. Johnsen, D. Kocot, A. Negaard, A. Skinningsrud, P. Gulbrandsen, A. Wallin, and T. Fladby
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
Neurology, September 12, 2006; 67(5): 830 - 833.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Yue, M. Lu, T. Lancaster, P. Cao, S.-I. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li
Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model
PNAS, December 27, 2005; 102(52): 19198 - 19203.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
L. W. Baum
Sex, Hormones, and Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 736 - 743.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
D. H. Taylor Jr., F. A. Sloan, and P. Murali Doraiswamy
Marked Increase in Alzheimer's Disease Identified in Medicare Claims Records Between 1991 and 1999
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): M762 - M766.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K A Jellinger
Traumatic brain injury as a risk factor for Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 511 - 512.
[Full Text] [PDF]


Home page
NeurologyHome page
S. D. Moffat, A. B. Zonderman, E. J. Metter, C. Kawas, M. R. Blackman, S. M. Harman, and S. M. Resnick
Free testosterone and risk for Alzheimer disease in older men
Neurology, January 27, 2004; 62(2): 188 - 193.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. D. Fisk, H. R. Merry, and K. Rockwood
Variations in case definition affect prevalence but not outcomes of mild cognitive impairment
Neurology, November 11, 2003; 61(9): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. S. Knopman, B. F. Boeve, and R. C. Petersen
Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308.
[Abstract] [PDF]


Home page
NEJMHome page
R. L. Nussbaum and C. E. Ellis
Alzheimer's Disease and Parkinson's Disease
N. Engl. J. Med., April 3, 2003; 348(14): 1356 - 1364.
[Full Text] [PDF]


Home page
GerontologistHome page
G. M. Martin
BIOLOGY OF AGING: THE STATE OF THE ART
Gerontologist, April 1, 2003; 43(2): 272 - 274.
[Full Text] [PDF]


Home page
Journals of Gerontology Series B: Psychological Sciences and Social ScienceHome page
E. G. Walsh, B. Wu, J. B. Mitchell, and L. F. Berkmann
Cognitive Function and Acute Care Utilization
J. Gerontol. B. Psychol. Sci. Soc. Sci., January 1, 2003; 58(1): S38 - 49.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. C. Petersen, J.C. Stevens, M. Ganguli, E. G. Tangalos, J.L. Cummings, and S. T. DeKosky
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 8, 2001; 56(9): 1133 - 1142.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K.L. Lapane, G. Gambassi, F. Landi, A. Sgadari, V. Mor, and R. Bernabei
Gender differences in predictors of mortality in nursing home residents with AD
Neurology, March 13, 2001; 56(5): 650 - 654.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. S. Albert and D. A. Drachman
Alzheimer's disease: What is it, how many people have it, and why do we need to know?
Neurology, July 25, 2000; 55(2): 166 - 168.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.